Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Ziekenhuis Netwerk Antwerpen - Campus Stuivenberg, Antwerp

Weill Cornell Medical Center, New York

Levine Cancer Institute, Charlotte

University of Florida, Gainesville

University of Alabama, Birmingham

Vanderbilt Ingram Cancer Center, Nashville

University of TN Medical Center, Knoxville

Mid-Ohio Oncology/ Hematology, Columbus

University of Cincinnati Health Barrett Center, Cincinnati

Karmanos Cancer Institute, Detroit

University of Iowa, Iowa City

Rush University Medical Center, Chicago

Tulane Medical Center, New Orleans

Baylor Charles Sammons Cancer Center, Dallas

The University of Texas, MD Anderson Cancer Center, Houston

Klinikum der Universitaet Muenchen - Campus Grosshadern, Munich

Klinikum rechts der Isar - Technische Universitaet Muenchen, III. Medizinische Klinik und Polyklinik, Munich

Banner MD Anderson Cancer Center, Gilbert

Universiaetsklinikum Ulm, Ulm

Comprehensive Cancer Center of Nevada, Las Vegas

Cedar Sinai Medical Center, Los Angeles

UCLA Medical Center, Los Angeles

Universitaetsklinikum Wuerzburg, Medizinische Klinik und Poliklinik II, Würzburg

Northwest Medical Specialities, PLLC, Tacoma

Medical Oncology Associates, PS, Spokane

Hackensack University Medical Center, Hackensack

Summit Medical Group, Morristown

CHU Brugmann, Brussels

Cliniques Universitaires Saint-Luc, Brussels

Universitair Ziekenhuis Gent, Ghent

UZ Leuven, Leuven

University Hospitals Birmingham NHS Foundation Trust, Birmingham

University Hospital of Wales, Cardiff

Northwick Park Hospital, Harrow

The Leeds Teaching Hospitals, Leeds

Kings College Hospital, London

University College London Hospitals, London

The Christie NHS Foundation Trust, Manchester

University Hospital Southampton NHS Foundation Trust, Southampton

The Royal Marsden NHS Foundation Trust, Sutton